Pathogenic variants specific for MDS‐type myeloid neoplasms were found by NGS in the NRAS, U2AF1 and ZRSR2 genes with VAFs of 40%, 24% and 6%, respectively. This evidence concerns the gene NRAS and myelodysplastic syndrome.